ArticlePharmaceutics2025

Pharmacogenomic Drug-Target Network Analysis Reveals Similarity Profiles Among FDA-Approved Cancer Drugs.

Alberto Berral-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.